Related Experiment Videos
Leucopenia associated with beta-lactam antibiotic therapy
Abstract:
Two cases of penicillin-induced and one case of cephalosporin-induced leucopenia are described. This unusual complication of widely used beta-lactam antibiotics can occur when these antibiotics are administered parenterally in high doses for prolonged periods (14 days or more). The close monitoring of the white cell count is important when treating patients with high doses of beta-lactam antibiotics for prolonged periods. We would like to emphasize that when penicillin- or cephalosporin-induced leucopenia is suspected, continuation with another beta-lactam antibiotic may be dangerous.
Insights
Beta-lactam antibiotics like penicillin and cephalosporin can cause leucopenia, a low white blood cell count. Monitor white cell counts during prolonged high-dose parenteral antibiotic therapy to prevent this rare but serious side effect.
Area of Science:
- Pharmacology
- Hematology
- Infectious Diseases
Background:
- Beta-lactam antibiotics, including penicillin and cephalosporins, are widely prescribed for bacterial infections.
- Parenteral administration of antibiotics is common in clinical practice for severe infections.
Observation:
- Two cases of penicillin-induced leucopenia and one case of cephalosporin-induced leucopenia were observed.
- Leucopenia is an uncommon but serious adverse effect associated with these antibiotics.
Findings:
- High-dose, prolonged parenteral administration (14 days or more) of beta-lactam antibiotics is linked to leucopenia.
- Leucopenia is characterized by a significant decrease in white blood cell count.
Implications:
- Close monitoring of white blood cell counts is crucial for patients receiving prolonged high-dose beta-lactam therapy.
- Discontinuation of the suspected beta-lactam agent is recommended if leucopenia is suspected.
- Continuing treatment with another beta-lactam antibiotic when leucopenia is suspected may pose significant risks.